Interpretive Rule
Commission Guidance Regarding Accounting for Sales of Vaccines and Bioterror Countermeasures to the Federal Government for Placement Into the Pediatric Vaccine Stockpile or the Strategic National Stockpile
Overview
The Securities and Exchange Commission (Commission) is publishing this interpretive release with respect to accounting for sales of vaccines and bioterror countermeasures to the Federal government for placement into stockpiles related to the Vaccines for Children Program or the Strategic National Stockpile.
Resources
Details
Rule Type
Interpretive
Release Number
33-8642
34-52885
IC-27178
SEC Issue Date
Dec. 5, 2005
Federal Register Publish Date
Dec. 9, 2005
Document Citation
70 FR 73343